CVE-2023-3631
Medart Notification Panel Project Medart Notification Panel SQL injection
- Published23 Nov 2023
Description
Improper Neutralization of Special Elements used in an SQL Command ('SQL Injection') vulnerability in Medart Health Services Medart Notification Panel allows SQL Injection. This issue affects Medart Notification Panel: through 20231123. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.
CVSS 3.1 breakdown
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:HAffected products
Remediation
No fixed version is recorded in the NVD data. Check the vendor advisory for the latest guidance.
References
Related CVEs
Recent high-severity vulnerabilities sharing a weakness type.
Frequently asked
Is CVE-2023-3631 being actively exploited?
CVE-2023-3631 is not in the CISA KEV catalog. Its EPSS exploit probability is 0.81%.
How severe is CVE-2023-3631?
CVE-2023-3631 has a CVSS 3.1 base score of 9.8, rated critical. EPSS estimates a 0.81% probability of exploitation.
Which products are affected by CVE-2023-3631?
Affected products include Medart Notification Panel Project Medart Notification Panel.
How do I fix CVE-2023-3631?
Apply the vendor's patch or advisory guidance, then verify no affected versions remain across your devices.
How Secuno handles this
Secuno correlates vulnerabilities like CVE-2023-3631 against the real software inventory on every managed device, every day. Rather than a static severity, each match is scored in context: exploit availability, EPSS, the asset's exposure, and business criticality decide where it lands in the queue. If an affected version is present anywhere across your portfolio, it surfaces automatically with a prioritised remediation path.
Data from the NVD, CISA KEV catalog and FIRST EPSS. CVSS 3.1 base score shown where available.